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1. Introduction
  
 Diabetes mellitus is a group of metabolic diseases 
portrayed by the rise of blood glucose levels caused 
by the flaws either in insulin secretion or action. 
A study proved that diabetes mellitus is caused by 
oxidative stress resulted from the increase of free 
radical formation in the body (Ullah et al. 2016). 
In vitro experiments on animals and humans 
demonstrated that the oxidative stress in humans and 
plants causes an elevated formation of free radicals in 
the pathophysiology resulting in many detrimental 
effects of diabetes towards renal, retinal neurological, 
cardiovascular functions (Chaudhuri and Umpierrez 
2012). 
 Orthosiphon aristatus, popularly known as Java 
tea, showed antihyperglycemic activities and had 
been utilized to alleviate diabetes conditions by the 
local Indonesian communities, which resulted in 
its popularity as alternative antidiabetic medicine 
(Miltonprabu 2019). Antihyperglycemic effect, 
observed following administration of Orthosiphon 
aristatus extract (1 g/kg) to streptozotocin (STZ) 
induced diabetic rat, was similar to that observed with 
glibenclamide (10 mg/kg) (Mohamed et al. 2011). The 
antihyperglycemic activities of Orthosiphon aristatus 
leaves might be due to their flavonoids and phenolic 
acid content as phytochemicals, which play a role in 
secondary metabolic compounds in plant protection. 
 Along with other herbs and spices, Java tea 
extract had been utilized to produce a functional 
drink with antioxidant activities and oxidative stress 
reduction (Wijaya et al. 2007, 2011). The RTD JTFD 
has been examined for the acute test and reported 
as relatively harmless (Soho 2014). The addition of 
ginger (Zingiber officinale) was reported to improve 
the antihyperglycemic activities of JTFD (Indariani et 
al. 2014). The increase of mice blood glucose level was 
suppressed by 25.95% by feeding the ginger-added 
drink; however, the blood glucose of mice fed with 
the drink without ginger increased by up to 91.75%.
 Ready-to-drink (RTD) Java tea-based products 
have its limitations in terms of transportation and 
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handling due to its volume and shelf life. These 
limitations could be addressed by converting it into an 
effervescent dried powder using nanoencapsulation 
technology, which allowed for easier handling and 
longer shelf-life (Cushen et al. 2012). Encapsulation 
of bioactive ingredients within a polysaccharide is 
crucial to protect them from degradation by reducing 
their exposure to unfavorable environmental factors 
while improving their bioactivities (Fathi et al. 2014). 
 Chitosan has been used as one of the main 
polysaccharides to create nanoparticles to improve 
the sustaining and targeting of drug delivery. 
Nanoparticles could function as a non-toxic and 
efficient carrier system while enhancing bioactive 
compounds' bioavailability within the cells and 
tissues (Khalil et al. 2016). Nanomaterials of 
nanoencapsulated JTFD powder consisted of FDA-
approved polymers for its human consumption 
(Sampathkumar et al. 2020).
 Nanoencapsulated effervescent JTFD showed 
particle size reduction by 57.19 % with a polydispersity 
index of 47.55%, suppressed bitter taste intensity 
(70.05%), and had preferable taste than the non-
nanoencapsulated one (Wijaya et al. 2013). However, 
the bioavailability of this nanoencapsulated 
beverage has not been explored yet. Therefore, 
this study sought to compare the effectiveness of 
RTD, nanoencapsulated, and microencapsulated 
effervescent JTFD to inhibit the hyperglycemic 
syndrome of STZ-induced diabetic rats.
2. Materials and Methods
2.1. Extract Preparation 
 Three types of JTFDs were prepared with the 
extracts of white-flowered Orthosiphon aristatus 
leaves (specimen No. BMK0076042016) obtained 
from Balittro Garden, West Java, Indonesia. On top 
of that, ginger (Zingiber officinale, specimen No. 
BMK0043052015), lime (Citrus aurantifolia, specimen 
No. BMK0202092016), kaffir lime (Citrus hystrix, 
specimen No. BMK0189092016), lemon (Citrus limon, 
specimen No. BMK0201092016), turmeric (Curcuma 
xanthorriza, specimen No. BMK0042072014), and 
sappan wood (Caesalpinia sappan, specimen No. 
BMK0120092016) were acquired from a local market 
in Bogor, West Java, Indonesia. Biopharmaca Research 
Center (Bogor Agricultural University, Indonesia) 
conducted all plant identification. 
 The extraction was performed based on Wijaya et 
al. (2007) by extracting 30 g of fresh Java tea leaves 
in 600 ml of boiling water for 15 min in a closed pan 
while 20 g of sappan wood was extracted in 500 ml 
boiling water for 15 min in a closed pan. Ginger (100 
g), turmeric (100 g), lime (100 g), lemon (250 g), and 
kaffir lime (100 g) were extracted separately using a 
juice extractor without the addition of water.
2.2. Preparation of JTFD
2.2.1. Preparation of RTD JTFD
RTD sample was prepared according to Febriani 
(2012) with modifications. Java tea extract (5.9 ml) 
was added into mixture of extracts that containing 
sappan wood (1.05 ml), ginger (1.52 ml), turmeric 
(0.2 ml), lemon (0.902 ml), lime (3.098 ml), and 
kaffir lime (1 ml). Carboxymethyl cellulose 10 ml 
(1% w/v) was added to the mixture. Aspartame 
0.0425 g, acesulfame 0.0157 g, and sucralose 0.0053 
g were added to the mixture. Water was added to 
the homogenous mixture until the volume reached 
100 ml. The concoction was added with sodium 
bicarbonate 2.16 g, 1.08 g of citric acid, and 0.76 g of 
tartaric acid just before feeding.
2.2.2. Preparation of Microencapsulated JTFD
Microencapsulated drink was prepared according 
to Kusumasari (2012). Initially, the drink was 
prepared similarly to the RTD with the addition of 
water to 100 ml. 100 g of 20 % maltodextrin solution 
(w/v) was then added, homogenized, and spray dried 
to produce a microencapsulated powder. The powder 
was then added with three sweeteners (0.0425 
g aspartame, 0.0157 g acesulfame, and 0.0053 g 
sucralose), along with other ingredients such as 2.16 
g of Na-bicarbonate, 1.08 g of citric acid, and 0.76 g 
of tartaric acid. The dried mixture (±4 g) was diluted 
in water, and the volume was measured up to 100 ml 
before feeding.
2.2.3. Preparation of Nanoencapsulated JTFD
Nanoencapsulated JTFD was synthesized by an 
ionic gelation method, according to Wijaya et al. 
(2013). Chitosan (Himedia Laboratories, Mumbai, 
India) solution was prepared by stirring acetic acid 
(Merck Chemical Company, Darmstadt, Germany) at 
room temperature for 3 h. This was followed by the 
addition of emulsifier tween 80 and a crosslinking 
agent (sodium tripolyphosphate (TPP). The mixture of 
extracts was concentrated using a rotary evaporator 
(final volume = 1/10 of initial volume) (Febriani 2012).
Emulsifier, crosslinking agent, and concentrated 
extract mixtures were added slowly by dropping 
consecutively into the chitosan solution under 
continuous stirring employing a magnetic stirrer 
for 3 hours at room temperature up until the 
nanosuspension had been formed and organic 
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solvent had been completely removed. 100 g of 
maltodextrin was then added to the nanosuspension 
before being homogenized for 4 minutes and spray 
dried (Mini Buchi 190, Flawil, Switzerland) to produce 
a nanoencapsulated powder. The product was then 
mixed with sweeteners (0.0425 g aspartame, 0.0157 
g acesulfame, and 0.0053 g sucralose), 2.16 g Na-
bicarbonate, 1.08 g citric acid, and 0.76 g of tartaric 
acid. The dried mixture (±4 g) was diluted in water, 
and the volume was measured up to 100 ml before 
feeding.
2.3. Particle Size and Polydispersity Index (PDI) 
Characterization
Size distributions and the average particle size of 
nanoencapsulated JTFD was measured using dynamic 
light scattering (Zetasizer Ver. 7.03, Malvern Instruments, 
Worcestershire, UK). All measurements were performed 
in triplicates. About 3 drops of the sample were put in 
the sample cell, covered and measured using NanoQ 
software with input data in the form of solvent refractive 
index and viscosity based on the laser beam's intensity 
on 30 distinct field points of each sample. The particle 
size and polydispersity index can be seen from the 
output of the cumulant method that is PDI (Davies 
et al. 2020).
2.4. Scanning Electron Microscope (SEM)
The morphology of JTFD powder was examined by 
scanning electron microscopy (SEM, Zeiss EVO MA10). 
The dry sample was covered with conductive carbon 
tapes and coated with a thin (<20 nm) conductive 
gold layer using a sputter-coater. A 20 kV of voltage 
was applied with 40 Pa of pressure and 5,000 times 
of magnification. The digital image of samples was 
obtained, and representative images are presented 
(Nallamuthu et al. 2015).
2.5. Determination of Total Phenolic Content 
Folin-Ciocalteu reagent was used to establish the 
total phenolic content (TPC) of all samples based 
on phenol's ability to reduce the Folin-Ciocalteu 
phosphomolybdate forming molybdenum blue. Gallic 
acid was employed as the standard reference (50-250 
ppm). 1 ml of each sample was added with 5 ml of water 
and 0.5 ml of Folin-Ciocalteu reagent (diluted to 50:50 
with de-ionized water) before neutralized with 1 ml of 
sodium carbonate solution (5% w/v). The concoction 
was kept at room temperature in the absence of light 
for 1 hour with occasional shaking to develop the final 
color. The absorbance was assessed by a double beam 
UV-Vis spectrophotometer (Shimadzu 2450, Kyoto, 
Japan) at 725 nm. The TPC was calculated using a linear 
regression equation of a gallic acid standard curve, 
reported as mean±SD (n = 3) and conveyed in ppm 
gallic acid equivalent (GAE) (Al-Owaisi et al. 2014).
2.6. Animals and Diet
Sprague Dawley albino male rats with body weights 
of 200-350 g (Mestry et al. 2017) were acquired from the 
experimental animal facility of The National Agency of 
Drugs and Food Control (BPOM) Republic of Indonesia. 
They were housed in box cages with wire mesh tops, 
provided with bedding material from sawdust, and 
divided into groups of three in a housing system. The 
rats were fed ad libitum in 50-60% relative humidity 
and artificial light (6.00 AM to 6.00 PM) along with 
a standard diet (14.74% carbohydrate, 17.31% protein, 
10.63% fat, 5.88% water, 31.63% ashes). Diabetes was 
induced by intraperitoneal injection of STZ (Sigma 
Chemical Co., St Louis, MO, USA) at 45 mg/kg of body 
weight (Mestry et al. 2017). 
STZ in 0.1 M of acetate buffer was induced after fasting 
for 18 hours. The rats were administered overnight 
with a 10% sucrose solution to alleviate STZ-induced 
hypoglycemia. Rats with a blood glucose level of ≥200 
mg/dl were deemed diabetic and used in this study 
(Premanath and Nanjaiah 2015). The experiments were 
carried out in a qualified animal breeding room in the 
Animal Laboratory of Tropical Biopharmaca Research 
Center IPB (Protocol fulfilled the guidelines described 
in The Animal Ethics Committee, Bogor Agriculture 
University, and had been approved with registration 
number: 20-2016 IPB).
2.6.1. Experimental Groups and Treatments
All rats were arbitrarily separated into five groups 
of three (Krayem and Sarker 2017). The groups were 
assigned as A, B, C, D, E, which consisted of normal 
rats, diabetic control rats fed with distilled water), 
diabetic rats fed with RTD drink, diabetic rats with 
microencapsulated drink, and nanoencapsulated drink, 
respectively. All liquids were force-fed (3.64 ml of 200 
g body weight) by an intragastric tube every morning 
for 14 days.
Functional drink feeding was started at 48 h after 
STZ injection (day 2). Feed intake, body weight, fasting 
blood glucose level, and physical examinations were 
determined periodically. The drink quantity was 
tweaked weekly based on the bodyweight changes 
to maintain similar doses per 200 g of body weight 
over the entire study period.
The amount of feed intake and body weight for all 
groups was measured on day -7, 0, 7, and 14. After 16 
days of the experiment, the rats were sacrificed through 
the injection of ketamine (Hospira, Lake Forest, USA) 
214                                                                                                                                                               Rekasih M et al.
HAYATI J Biosci                                                                                                                                                                     215
Vol. 28 No. 3, July 2021
at 80 mg/kg of body weight and xylazine (Syntec, Rio 
Cotia, Brazil) at 10 mg/kg of body weight. Pancreas 
tissue was collected for various experimental analyses 
(2 rats in each group).
2.6.2. Testing of Fasting Blood Glucose Level
Measurements of fasting blood glucose level, 
expressed in milligram per deciliter of blood, was 
conducted on day 0, before the STZ injection, day 2, 
9, and 16 after injection of 45 mg/kg of body weight. 
The blood sample obtained from the tail vein of 18 h 
fasting rats was obtained to measure the blood glucose 
level using an electronic glucometer kit (Accu-Chek, 
Roche diabetes care, Indianapolis, Indiana) (Morakinyo 
et al. 2015).
2.6.3. Histopathological Study
A part of the pancreatic tissue was dissected out 
and washed with phosphate saline buffer pH 7.4, fixed 
in 10% of buffered formal saline, and embedded in 
paraffin. Fixed sections were cut at 5 µm and stained 
with an immune histochemical assay. The section was 
examined and photographed under a light microscope, 
according to Abunasef et al. (2014) methods.
2.6.4. β-cell and Langerhans islets viability
An immunohistochemical assay was applied to 
analyze the viability of β-cell and Langerhan's islet. 
The percentage of cell viability was determined by 
dividing the cells treated (brown color) by the total 
number of normal cells in control x 100 % (Ghorbani 
et al. 2015). 
2.7. Statistical and Analysis of Data
Statistical significance of the biochemical effects 
was determined by one-way ANOVA using a general 
linear model procedure of SPSS version 22 software 
(SPSS Institute, Inc., Chicago, IL, USA) and Duncan's 
post hoc test at 95% confidence intervals.
3. Results
3.1. Particle Size and Morphology Observation 
of Java Tea Nanoencapsulation
The particle size and polydispersity index of 
nanoencapsulated JTFD is presented in Figure 
1. The scanning electron microscope image of 
nanoencapsulated JTFD powder is presented in Figure 2.
3.2. TPC of Various JTFD
Figure 3 showed the TPC of RTD, microencapsulated, 
and nanoencapsulated JTFD, shown as gallic acid 
equivalent. The result showed that the highest TPC 
was found in RTD drink, while the lowest one was 
found in nanoencapsulated one (p<0.05). 
3.3. Blood Glucose Level Profile in Rats
The rat blood glucose level after 14 days of orally 
administered JTFDs is presented in Figure 4. The study 
showed that normal glucose levels were between 94-123 
mg/dl. STZ induction caused a significant increase in 
blood glucose levels (p<0.05) on day 2 when compared 
with the control (A). Some elevation that was within 
the normal range of blood glucose levels occurred in 
control (A) group during the acclimation days with 
no significant difference (p<0.05). The blood glucose 
level of STZ-induced rats decreased on day 9 and the 
percentage of blood glucose level alteration could be 
seen in Table 1. The blood glucose level of diabetic 
control (B) rats decreased significantly on day 9 (p<0.05). 
JTFD administration could suppress the blood glucose 
level on day 9. Nanoencapsulated JTFD was the most 
effective to suppress blood glucose into a level that 
was not significantly different (p<0.05) towards day 
2. Diabetic rats treated with microencapsulation (D) 
and RTD (C) JTFD showed lower blood glucose levels. 
The blood glucose level in diabetic control (B) 
increased significantly (p<0.05) on day 16. Meanwhile, 
as shown in Figure 4, the administration of JTFDs could 
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Figure 1. The diameter avarage and polydispersity index of 
nanoencapsulated JTFD
Figure 2. The surface morphology of nanoencapsulated 
JTFD at magnification of 5,000 X
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the elevation of blood glucose levels; however, it could 
not lower the elevation of blood glucose levels on day 2. 
Microencapsulated and nanoencapsulated JTFDs could 
slightly reduce blood glucose levels.
The blood glucose-lowering ability of 
nanoencapsulated JTFD for 14 days seems similar to 
the microencapsulated JTFD. However, based on the 
pattern of changes in blood glucose levels during 16 
days of the study, the nanoencapsulated JTFD was more 
effective in stabilizing blood glucose levels than the 
microencapsulated beverage (Figure 4).
3.4. Feed Intake of Rats
During the experimental period, each group's feed 
intake and body weight were continuously monitored 
(Figure 5). All rats showed a stable feed intake at 7 days 
before STZ induction until day 0. After induced STZ, 
the feed intake of diabetic rats decreased significantly 
(p<0.05) from day 0 until day 7. The decreasing 
percentage of feed intake is presented in Table 2. The 
highest decreasing feed intake was shown by positive 
control (B).  As shown in Table 2, the administration 
of all types of JTFDs could suppress the reduction of 
feed intake. Nanoencapsulated JTFD was the most 
effective sample to suppress the feed intake reduction 
compared to other JTFDs while RTD JTFD showed the 
lowest suppressing effect.
Diabetic control (B) continued to decrease the intake 
of feed until day 14, and it was significantly different 
from day 0 (before STZ induced). The percentage of 
feed intake was decreasing from day 0 to day 14. On 
the contrary, the diabetic rats treated with JTFD showed 
increasing feed intake until there was no feed left from 
day 7 to day 14.
3.5. Bodyweight of Rats
The body weight of all rats was continuously 
observed, as could be seen in Figure 6. The percentage 
of reduction in body weight from each group is 
presented in Table 3. Normal control (A) exhibited an 
increase in body weight significantly (p<0.05) from 
7 days before STZ induction to day 0, whereas other 
groups tended to be stable.
STZ induction caused a decrease in body weight 
from day 0 to day 7, but it did not show a significant 
Table 1. The percentage of decreasing blood glucose during 
treatment
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Figure 4. The effect of 3 various kinds of JTFD on blood 
glucose level of rat (before and during treatment).
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Figure 5. The effect of 3 various kinds of JTFD on feed intake of rat (before and during treatment)
Figure 6. The effect of 3 various kinds of JTFD on body weight of rat (before and during treatment)
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difference (p<0.05). This phenomenon also occurred 
in control (A). The rats' body weight continued 
to increase significantly (p<0.05) until day 14. It 
showed that normal control rats' body weight 
increased significantly (p<0.05) during acclimation. 
On the contrary, diabetic control (B) body weight 
significantly decreased continuously until day 14.
3.6. Effect on Langerhans and β-cell Morphology
The existence of pancreatic β-cell was observed by 
a negative or positive reaction to staining with anti-
insulin immunohistochemical methods characterized 
by the formation of brown color (Figure 7). β-cells 
that were shrunken showed an adverse reaction 
towards anti-insulin as it did not form a brown 
color during preparations. Based on a qualitative 
immunohistochemical test, the pancreas of normal 
control (A) showed a strong immunoreactivity 
towards insulin secreted by β-cells, as shown by 
the high intensity of brown color. Diabetic control 
(B) showed a lack of insulin secretion by the β-cell 
in Langerhans islets. The diabetic rats treated with 
JTFDs showed an increase in the secretion of insulin. 
As shown in Figure 7, the rats treated with RTD JTFD 
(C) showed less immunoreactivity than the group 
treated with a microencapsulated JTFD (D). Diabetic 
rats treated with nanoencapsulated JTFD (E) showed 
the most significant regeneration of β-cell, indicated 
by increased expression of β-cell expression 
compared to the diabetic control (B).
The ability of RTD, microencapsulated, and 
nanoencapsulated JTFDs in repairing or suppressing 
the damage of β-cell compared to the one without 
JTFD was clearly shown in Figure 7. Quantitatively, 
the amount of β-cell and Langerhans islets in 
immunohistochemical staining can be used to 
calculate the viability of β-cell and Langerhans 
islets (Table 4). The administration of RTD and 
microencapsulated beverages improved the viability 
of β-cells and Langerhans islets than that of positive 
group (B), but it was not significantly different. 
Nanoencapsulated beverage significantly maintained 
the viability of β-cell function and Langerhans islets 
(p<0.05) compared to the viability of diabetic control 
(B).
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a b c
ed
Figure 7. β cells in Langerhan with antiinsulin antibody imunohistochemical staining at scale bar = 50 µm
Table 4. The percentage of β cell and Langerhans islet 
viability
Value with same superscript letter within group are not 
statistically different at significant level of p<0.05 by 
using Duncan test. a = control of viability of β-cell. ab 
= able to improve the viability of β-cell, but it was not 
significantly different with control. b = most capable in 




















 The particles in the nanoencapsulated JTFD were 
proved as nanoparticles, which is defined as any 
particulate materials with a size of 1 to 1,000 nm (Food 
and Drug Administration 2012). The particle size 
of the nanoencapsulated drink in this research was 
larger than that of Wijaya et al. (2013), presumably 
due to the differences in the degree of deacetylation 
of chitosan used (Elgadir et al. 2015). The higher 
degree of deacetylation in chitosan causes stronger 
break strength, resulting in the smaller size of the 
nanoparticles (Babii et al. 2020). Wijaya et al. (2013) 
used chitosan >90 % degree of deacetylation, whereas 
this study used >75% degree of deacetylation. The 
concentration of TPP and chitosan is also associated 
with the increase of particle size. Crosslinking, which 
connects TPP and chitosan, affects the increase of 
viscosity and homogenization capabilities, leading to 
aggregates with large particle size.
 Nanoencapsulated JTFD was included in 
monodisperse systems. PDI represented the 
particle distribution, where 0.0 represents a narrow 
distribution, and 1.0 represents an extensive 
distribution based on Jayapraksha et al. (2016).
 The particles of nanoencapsulated JTFD powder 
were aggregated by melting and attaching. The 
spherical shape and various sizes of particles are 
typical of spray-dried powders. This morphology 
was found in previous observation nanoliposomes 
loaded with flaxseed-peptide fractions (Sarabandi 
and Jafari 2020). The full sphere indicates the 
successful encapsulation process because the 
bioactive compounds were encapsulated inside the 
sphere.
 Encapsulation might have lowered the total 
phenolic contents of the encapsulated Java tea-based 
functional beverages compared to the RTD beverage's 
total phenolic content. The diffusion mechanism 
of releasing the active compounds in encapsulated 
beverages might need longer diffusion time than non-
encapsulated. The bioactive compounds, chitosan, 
and other additives in the nanoencapsulated process 
have formed in a homogeneous system, causing 
the least amount of OH group, which reduced 
phosphotungstate and phosphomolybdate in the 
Folin-Ciocalteu reagent utilized in the amount of 
phenol compounds calculation. Nalamuthu et al. 
(2015) showed the release of bioactive compounds in 
encapsulated material runs slower than those in non-
encapsulated in an in-vitro test. Moreover, the smaller 
the particle size, the stronger the contact area and 
intermolecular forces between the particles would 
be (Opalinski et al. 2016). Therefore, the process of 
releasing OH is more difficult in nanoencapsulated 
materials than that in microencapsulated materials.
 TPC of the RTD sample was more significant than 
the one found by Indariani et al. (2014), presumably 
because of the addition of lemon extract. Lemons are 
rich in phenolic compounds that possess antioxidant 
activity (Fancello et al. 2016). 
 All rats had normal blood glucose levels on day 
0 based on Yang et al. (2016) study. The increase of 
blood glucose levels after the STZ-administration 
(day 2) indicated hyperglycemic conditions (Uma et 
al. 2014). The reduction of the blood glucose level of 
diabetic control (B) rats was harmful to rats and should 
be avoided (Ullah et al. 2016). The decreasing blood 
glucose level on day 9 in the diabetic group (B) might 
be caused by the significant reduction of feed intake, 
resulting in a lower amount of entering nutrients 
(Pwaniyobo et al. 2020). This decline of glucose levels 
can be harmful if there is no glucose during starvation, 
especially when there is no glycogen in the liver. This 
heavy transitional hypoglycemia results from insulin 
excess, which is due to STZ induction, causing the 
lysis of cell membrane, plasma membrane, and other 
subcellular organelles, including Golgi complex and 
rough endoplasmic reticulum. The outer and inner 
membranes of the mitochondria have structural 
changes in this phase. The expression of functionally 
essential proteins such as glucose transporter GLUT2, 
glucokinase, and insulin protein is undetectable 
(Karim et al. 2012).
 The small size of the nanoparticle can increase 
the beverage's contact surface, which may cause a 
faster regeneration of β-cells (Samadder et al. 2012). 
The administration of nanoencapsulated JTFD for 14 
days was more effective in suppressing the increase 
of blood glucose levels in diabetic rats (declined 
blood glucose level) than the administration of RTD 
JTFD (suppressed the elevation of blood glucose). 
This study proved that the encapsulation improved 
bioactive compounds' resistance and bioavailability, 
as reported by Jang et al. (2013). This study supports 
previous research stating that a decrease of blood 
glucose level in Mus musculus force-fed with 
nanoencapsulated extracts of Syzygium jambolanum 
for 14 days better than that in the diabetic rats fed by 
extracts of non-encapsulation (Samadder et al. 2012).
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 STZ-induced diabetic rats at dose 45 mg/kg of body 
weight were characterized by the decline of body 
weight and feed intake. This result is in accordance 
to the other group studies, which showed similar 
weight loss by the administration of Piper crocatum 
extract beverage (1,260 mg/kg body weight) to 
Sprague Dawley rats induced by STZ 50 mg/kg body 
weight and administration of mixed beverage of red 
betel extract after 14 days (Hasibuan et al. 2016). The 
decrease in diabetic rats’ body weight was caused 
by reduced glucose metabolism and increased fat 
metabolism (Guo et al. 2018). During this period, the 
animal models looked pale and skinny, suffered hair 
loss, and the hair turned yellow (Adeyi et al. 2012). 
Administration of JTFD all variants could increase the 
appetite, resulting in a lower reduction of feed intake 
than that of diabetic control (B). It showed that JTFD 
was a good supplement to diabetic rats as indicated 
by Indariani et al. (2014). Diabetic rats treated with 
nanoencapsulated JTFD (E) could stabilize their body 
weight. Microencapsulated beverages showed higher 
suppression of the reduction of rat body weight than 
RTD JTFD in 14 days of oral administration. This ability 
might be due to the fulfillment of energy due to the 
improvement of glucose absorption by repairing 
glucose absorption and optimizing fat utilization. 
The RTD JTFD showed the weakest ability to suppress 
the decrease in body weight and feed intake.
 The induction of STZ could change the pancreatic 
morphology of rats. Depreciation of Langerhans islet 
in diabetic rats might be caused by the loss of β-cell, 
which allegedly was caused by the alkylation and 
activity of NO STZ radical in DNA cell (Smirnov et al. 
2012). The morphology of Langerhans islet has been 
reported by Wu et al. (2016). JTFD has been reported 
to improve Langerhan's islet (Indariani et al. 2014). 
The ability of nanoencapsulated JTFD as the most 
effective beverage in repairing the morphology of 
Langerhans islet (Figure 7) was aligned with its ability 
to suppress the increase of blood glucose levels and 
to suppress the decrease of feed intake and body 
weight.
 The increase of β-cell number allegedly could 
increase the insulin levels, as reported by Hasibuan 
et al. (2016). In the present study, nanoencapsulated 
bioactive compounds might have more significant 
advantages due to the protection of active compounds 
on the way towards the target cell, inducing 
higher bioavailability of bioactive compounds of 
nanoencapsulated JTFD and due to an increase of the 
surface area of nanoencapsulated JTFD that improves 
the cell reparation. This study was in accordance 
with another study showing that nanoencapsulated 
Syzygium jambolanum extract resulted in better 
protection and improvement of L6 cells in diabetic 
rats induced by arsenic comparing to the non-
encapsulated extract (Samadder et al.  2012).
5. Conclusion
 Java tea-based functional drink (JTFD) was 
successfully encapsulated using nanoencapsulation 
technology, and the particles dominantly had 
spherical shape morphology. All types of JTFDs 
suppressed the increase of blood glucose levels 
in diabetic rats. Nanoencapsulated JTFD was the 
most effective in lowering blood glucose levels, 
maintaining the feed intake, and stabilizing the body 
weight of diabetic rats by protecting the viability of 
β-cell and the islets of Langerhans. The findings may 
support the nanoencapsulation of Java tea-based 
functional effervescent drink as a new way to control 
blood glucose levels. 
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